CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 15,280	$ 8,941
General and administrative	7,520	4,789
Total operating expenses	22,800	13,730
Loss from operations	(22,800)	(13,730)
Other income:
Interest income	63	7
Total other income	63	7
Net loss	(22,737)	(13,723)
Cumulative dividends on redeemable convertible preferred stock		(1,228)
Net loss attributable to common stockholders	$ (22,737)	$ (14,951)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.61)	$ (0.67)
Weighted-average common shares outstanding, basic and diluted	37,293,438	22,263,994
Other comprehensive loss:
Unrealized loss on available for sale investments	$ (1,072)
Total other comprehensive loss	(1,072)
Comprehensive loss attributable to common stockholders	$ (23,809)	$ (14,951)